These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 11144313)
1. Survival after intrauterine myocardial infarction: noninvasive assessment of myocardial perfusion with 99mTc-Sestamibi scintigraphy. Birnbacher R; Salzer-Muhar U; Kurtaran A; Marx M; Kuhle S; Pollak A Am J Perinatol; 2000; 17(6):309-13. PubMed ID: 11144313 [TBL] [Abstract][Full Text] [Related]
2. [Planar myocardial scintigraphy with technetium-99m-sestamibi in acute myocardial infarct treated with thrombolytic therapy]. Zammarchi A; Pitscheider W; Mautone A; Oberhollenzer R; Lintner W; Erlicher A; Crepaz R; Osele L; Braito E G Ital Cardiol; 1995 Aug; 25(8):1011-9. PubMed ID: 7498619 [TBL] [Abstract][Full Text] [Related]
3. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium. Sciagrà R; Bisi G; Santoro GM; Rossi V; Fazzini PF Am J Card Imaging; 1995 Jul; 9(3):157-66. PubMed ID: 7549355 [TBL] [Abstract][Full Text] [Related]
4. Prediction of recovery of left ventricular dysfunction after acute myocardial infarction: comparison between 99mTc-sestamibi cardiac tomography and low-dose dobutamine echocardiography. Spinelli L; Petretta M; Cuocolo A; Nicolai E; Acampa W; Vicario L; Bonaduce D J Nucl Med; 1999 Oct; 40(10):1683-92. PubMed ID: 10520709 [TBL] [Abstract][Full Text] [Related]
5. Technetium-99m sestamibi tomographic evaluation of residual ischemia after anterior myocardial infarction. Marcassa C; Galli M; Temporelli PL; Campini R; Orrego PS; Zoccarato O; Giordano A; Giannuzzi P J Am Coll Cardiol; 1995 Mar; 25(3):590-6. PubMed ID: 7860901 [TBL] [Abstract][Full Text] [Related]
6. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease]. vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949 [TBL] [Abstract][Full Text] [Related]
7. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. Takeishi Y; Sukekawa H; Fujiwara S; Ikeno E; Sasaki Y; Tomoike H J Nucl Med; 1996 Aug; 37(8):1289-94. PubMed ID: 8708758 [TBL] [Abstract][Full Text] [Related]
8. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability. Marzullo P; Sambuceti G; Parodi O J Nucl Med; 1992 Nov; 33(11):1925-30. PubMed ID: 1432150 [TBL] [Abstract][Full Text] [Related]
9. Postinfarction stress testing and one year outcome of stable patients after myocardial infarction treated with thrombolytics. Wagner S; Schuster S; Zahn R; Sattler B; Senges J Eur J Med Res; 1996 Nov; 1(12):575-81. PubMed ID: 9438166 [TBL] [Abstract][Full Text] [Related]
10. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction. Hambye AS; Dobbeleir AA; Vervaet AM; Van den Heuvel PA; Franken PR J Nucl Med; 1999 Sep; 40(9):1468-76. PubMed ID: 10492367 [TBL] [Abstract][Full Text] [Related]
11. Clinical validation of automatic quantitative defect size in rest technetium-99m-sestamibi myocardial perfusion SPECT. Kang X; Berman DS; Van Train KF; Amanullah AM; Areeda J; Friedman JD; Kiat H; Germano G J Nucl Med; 1997 Sep; 38(9):1441-6. PubMed ID: 9293805 [TBL] [Abstract][Full Text] [Related]
12. 201Tl and 99mTc-labeled sestamibi for assessment of myocardial viability. Sciagrà R; Bisi G; Santoro GM J Nucl Cardiol; 1996; 3(5):453-4. PubMed ID: 8902680 [No Abstract] [Full Text] [Related]
13. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. Franken PR; Dendale P; De Geeter F; Demoor D; Bossuyt A; Block P J Nucl Med; 1996 May; 37(5):718-22. PubMed ID: 8965133 [TBL] [Abstract][Full Text] [Related]
14. [Myocardial perfusion scintigraphy with 99mTC-sestamibi and gated SPECT and myocardial perfusion scintigraphy with reinjection of 201Tl at 24 hours. Are the techniques comparable?]. Fuster D; Solà M; Magriñá J; García A; Pavía J; Vidal-Sicart S; Huguet M; Muxí A Rev Esp Med Nucl; 1999 Jun; 18(3):169-75. PubMed ID: 10431064 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of hemodynamic significance of arteriovenous coronary fistulas: diagnostic integration of coronary angiography and stress/rest myocardial scintigraphy]. Rubini G; Ettorre GC; Sebastiani M; Bovenzi F Radiol Med; 2000 Dec; 100(6):453-8. PubMed ID: 11307506 [TBL] [Abstract][Full Text] [Related]
16. Potential and limitations of Tc-99m sestamibi scintigraphy for the diagnosis of myocardial viability. Cornel JH; Arnese M; Forster T; Postma-Tjoa J; Reijs AE; Fioretti PM Herz; 1994 Feb; 19(1):19-27. PubMed ID: 8150411 [TBL] [Abstract][Full Text] [Related]
17. [Comparison between myocardial perfusion scintigraphy with thallium-201 and technetium-99m-Sestamibi (methoxy isobutyl isonitrile) for the detection of coronary atherosclerotic disease]. Taillefer R; Lambert R; Grégoire J; Essiambre R; Phaneuf DC Union Med Can; 1990; 119(6):322, 324, 326-9. PubMed ID: 2150134 [TBL] [Abstract][Full Text] [Related]
18. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439 [TBL] [Abstract][Full Text] [Related]